Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of a metabolic agent in Japan (jRCT2080225046)
jRCT2080225046Phase 2Completed
- Start
- Feb 2020
01
Overview
Phase 2 trial. Started Feb 2020; status: completed.
Beyond the preview
Go deeper on jRCT2080225046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225046.